Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank 薬物名（臨床試験情報から抽出） KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Dexmedetomidine 3件: Dexmedetomidina; Dexmedetomidine; Dexmedetomidine hydrochloride2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬15件: 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
2 Nitroprusside 1件: Sodium nitroprusside1件: Sodium nitroprusside (SODIUM NITROPRUSSIDE IN 0.9% SODIUM CHLORIDE) 💬 --1件: 51 💬
3 Sodium chloride 2件: Natriumchlorid; Sodium chloride1件: Sodium chloride (0.9% SODIUM CHLORIDE, 0.9% SODIUM CHLORIDE INJECTION, 500ML, DRE BIOLAB, TOTALCARE) 💬 --23件: 2, 11, 13, 14, 34, 41, 46, 51, 53, 60, 67, 70, 96, 97, 193, 214, 215, 226, 227, 228, 288, 298, 299 💬
4 Vasopressin 1件: Vasopressin1件: Vasopressin (VASOPRESSIN IN 0.9% SODIUM CHLORIDE) 💬 3件: AVPR1A,
AVPR1B,
AVPR2 💬 		6件: Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬2件: 210, 225 💬